ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Otolaryngology

Top Otolaryngology Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ELIAS AYOUB M.D.

Otolaryngology

4,515

$249K

1148
963 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 21%

$55
Average prescription price

Avg: $50

OSMUND CHAN M.D.

Otolaryngology

2,258

$224K

737
692 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 21%

$99
Average prescription price

Avg: $50

ALI NAMAZIE MD

Otolaryngology

2,234

$128K

768
674 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 21%

$57
Average prescription price

Avg: $50

MICHEL BABAJANIAN M.D.

Otolaryngology

2,139

$115K

743
706 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 21%

$54
Average prescription price

Avg: $50

GERARD CARVALHO M.D.

Otolaryngology

2,041

$87.6K

685
531 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 21%

$43
Average prescription price

Avg: $50

BAC NGUYEN MD

Otolaryngology

1,945

$120K

474
388 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 21%

$62
Average prescription price

Avg: $50

ROBERT HABBESTAD MD

Otolaryngology

1,827

$106K

321
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

28%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 21%

$58
Average prescription price

Avg: $50

JAMES MONTAGANO M.D.

Otolaryngology

1,671

$123K

498
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 21%

$73
Average prescription price

Avg: $50

ANDREW MESTER M.D.

Otolaryngology

1,622

$36.2K

425
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

5%
prescriptions for brand name drugs

Avg: 21%

$22
Average prescription price

Avg: $50

NGHIA NGUYEN M.D.

Otolaryngology

1,596

$112K

428
394 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 21%

$70
Average prescription price

Avg: $50

SOL SILBERSTEIN M.D.

Otolaryngology

1,569

$84.5K

420
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 21%

$54
Average prescription price

Avg: $50

JAMES LEE M.D.

Otolaryngology

1,524

$94.6K

592
544 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 21%

$62
Average prescription price

Avg: $50

LAD RUBAUM MD

Otolaryngology

1,441

$319K

162
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 21%

$221
Average prescription price

Avg: $50

CARLOS JIMENEZ MD

Otolaryngology

1,406

$53.2K

517
449 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 21%

$38
Average prescription price

Avg: $50

MARC COLMAN MD

Otolaryngology

1,383

$57.9K

355
327 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 21%

$42
Average prescription price

Avg: $50

JORY KAPLAN M.D.

Otolaryngology

1,366

$56.6K

261
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 21%

$41
Average prescription price

Avg: $50

CHARLES SCHNEIDER M.D.

Otolaryngology

1,362

$149K

321
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 21%

$109
Average prescription price

Avg: $50

CLIFFORD CHEW MD

Otolaryngology

1,323

$50.6K

543
496 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$38
Average prescription price

Avg: $50

JAMES KALKANIS MD

Otolaryngology

1,313

$48.8K

414
350 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 21%

$37
Average prescription price

Avg: $50

MARK SPITZER

Otolaryngology

1,226

$72.7K

301
218 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 21%

$59
Average prescription price

Avg: $50

MADISON RICHARDSON MD

Otolaryngology

1,206

$83.1K

198
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 21%

$69
Average prescription price

Avg: $50

CHRISTOPHER WALZ M.D.

Otolaryngology

1,186

$55.6K

406
373 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 21%

$47
Average prescription price

Avg: $50

JOHN SAAD M.D.

Otolaryngology

1,139

$61.3K

356
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 21%

$54
Average prescription price

Avg: $50

CHARLES JOHNSON M.D.

Otolaryngology

1,137

$36.7K

346
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 21%

$32
Average prescription price

Avg: $50

JOHN TAYLOR MD

Otolaryngology

1,133

$35.9K

416
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 21%

$32
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank